Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Ailomics Therapeutics Logo
Ailomics Therapeutics Growth Score
85
CB Rank
527519
Heat Score
49
Ailomics Therapeutics focuses on developing innovative drugs to treat immune diseases and tumors.
Founded
obfuscation
PrivateAngel Shanghai, Shanghai, China11-50 www.ailomics.com
Biotechnology
Pharmaceutical
Therapeutics
Overview

Ailomics Therapeutics
Growth Score
85
Heat Score
49

Growth Score85
-2 pts
in past quarter
Heat Score 49
2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Ailomics Therapeutics

CB Rank
527519
Ailomics Therapeutics focuses on developing innovative drugs to treat immune diseases and tumors.
Founded
obfuscation
PrivateAngel Shanghai, Shanghai, China11-50 www.ailomics.com
Biotechnology
Pharmaceutical
Therapeutics

Funding Rounds

Angel
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Operating Status Active
Company Type For Profit
About the Company
Ailomics Therapeutics focuses on developing innovative drugs to treat immune diseases and tumors. Ailomics Therapeutics was founded in 2022 and was headquartered in Shanghai, China.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Computational Platform for Target Discovery
A platform that analyzes patient-derived omics data using AI to identify novel disease targets driving disease progression.
Human Disease Models
In vitro and in vivo disease models derived from patient samples to validate targets and screen therapeutic molecules.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Angel Round - Ailomics Therapeutics Logo
Angel Round - Ailomics Therapeutics
1
obfuscation
— Angel
obfuscation
Angel Round - Ailomics Therapeutics Logo
Angel Round - Ailomics Therapeutics
1
obfuscation
— Angel
obfuscation
Angel Round - Ailomics Therapeutics Logo
Angel Round - Ailomics Therapeutics
1
obfuscation
— Angel
obfuscation
Angel Round - Ailomics Therapeutics Logo
Angel Round - Ailomics Therapeutics
1
obfuscation
— Angel
obfuscation
Angel Round - Ailomics Therapeutics Logo
Angel Round - Ailomics Therapeutics
1
obfuscation
— Angel

Funding Rounds

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Angel Round - Ailomics Therapeutics Logo
Angel Round - Ailomics Therapeutics
1
obfuscation
— Angel
obfuscation
Angel Round - Ailomics Therapeutics Logo
Angel Round - Ailomics Therapeutics
1
obfuscation
— Angel
obfuscation
Angel Round - Ailomics Therapeutics Logo
Angel Round - Ailomics Therapeutics
1
obfuscation
— Angel
obfuscation
Angel Round - Ailomics Therapeutics Logo
Angel Round - Ailomics Therapeutics
1
obfuscation
— Angel
obfuscation
Angel Round - Ailomics Therapeutics Logo
Angel Round - Ailomics Therapeutics
1
obfuscation
— Angel

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News
Technology
View Tech Report

Monthly Web Visits

272
504.44%
 in past month

Active Website Tech Count

2Ailomics Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 100m.

Total IP

1Ailomics Therapeutics has 1 registered trademark in the 'Pharmaceutical, veterinary and sanitary products' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Ailomics Therapeutics's headquarters? Ailomics Therapeutics is located in Shanghai, Shanghai, China.Who invested in Ailomics Therapeutics? Ailomics Therapeutics is funded by Qiming Venture Partners.When was the last funding round for Ailomics Therapeutics? Ailomics Therapeutics closed its last funding round on
obfuscation
from a Angel round.Who are Ailomics Therapeutics's competitors? Alternatives and possible competitors to Ailomics Therapeutics may include Tempus, Insilico Medicine, and  Generate Biomedicines.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|